Intercept Pharmaceuticals...

NASDAQ: ICPT · Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM

Intercept Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
50.52M 84.71M
Short-Term Investments
435.05M 334.98M
Long-Term Investments
n/a n/a
Other Long-Term Assets
12.6M 15.23M
Receivables
26.86M 47.62M
Inventory
6.46M 8.62M
Other Current Assets
22.36M 25.29M
Total Current Assets
540.13M 502.29M
Property-Plant & Equipment
987K 9.5M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
13.58M 24.73M
Total Assets
553.71M 527.02M
Account Payables
14.23M 18.13M
Deferred Revenue
n/a 136.69M
Short-Term Debt
109.57M 3.04M
Other Current Liabilities
106.27M 8.95M
Total Current Liabilities
230.08M 166.82M
Long-Term Debt
223.1M 544.17M
Other Long-Term Liabilities
7.45M n/a
Total Long-Term Liabilities
230.56M 544.17M
Total Liabilities
460.63M 710.99M
Total Debt
332.67M 547.21M
Common Stock
42K 30K
Retained Earnings
-2.14B -2.49B
Comprehensive Income
-8.26M -2.87M
Shareholders Equity
93.08M -183.96M
Total Investments
435.05M 334.98M